
    
      Food effect will be assessed by comparing the pharmacokinetic (PK) parameters of a single
      dose of ACT-541468 under fasted (Treatment B) and fed (Treatment C) conditions.

      Potential CYP3A4 inhibiting / inducing effects of ACT-541468 will be assessed by comparing
      the PK parameters of midazolam alone (Treatment A) and midazolam given with a single dose of
      ACT-541468 (Treatment B) or with multiple doses of ACT-541468 (Treatment D).
    
  